You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Folate Receptor

Showing 1 - 25 of 7,403
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Endometrial Cancer Trial in New Haven (IMGN853)

Recruiting
  • Endometrial Cancer
  • New Haven, Connecticut
    Smilow Cancer Hospital at Yale New Haven
Aug 10, 2022

Ovarian Cancer Trial in Philadelphia (OTL38, intraoperative imaging camera system)

Withdrawn
  • Ovarian Cancer
  • OTL38
  • intraoperative imaging camera system
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Jun 23, 2022

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in Philadelphia (MOv19-BBz CAR T cells, Alpha Folate

Recruiting
  • Ovarian Cancer
  • +2 more
  • MOv19-BBz CAR T cells
  • Alpha Folate Receptor expression test
  • Philadelphia, Pennsylvania
    University of Pennsylvania Health System
Sep 12, 2022

Breast Tumor, Neoplastic Cells, Circulating Trial in Handan (Peripheral blood sampling for circulating tumor cells)

Active, not recruiting
  • Breast Neoplasm
  • Neoplastic Cells, Circulating
  • Peripheral blood sampling for circulating tumor cells
  • Handan, Hebei, China
    Kunwu Yan
Jan 26, 2023

Ovarian Cancer, Ovarian Carcinoma, Ovary Cancer Trial in United States (STRO-002, Bevacizumab)

Recruiting
  • Ovarian Cancer
  • +4 more
  • Tampa, Florida
  • +5 more
Aug 1, 2022

Bilateral Breast Carcinoma, Breast Inflammatory Carcinoma, Stage IB Breast Cancer AJCC v7 Trial in United States (drug, other,

Active, not recruiting
  • Bilateral Breast Carcinoma
  • +11 more
  • Scottsdale, Arizona
  • +11 more
Jan 12, 2023

Lung Tumors, Lung Cancer Trial in United States (OTL38 for Injection, Near infrared camera imaging system)

Completed
  • Lung Neoplasms
  • Lung Cancer
  • OTL38 for Injection
  • Near infrared camera imaging system
  • Stamford, Connecticut
  • +11 more
May 27, 2022

Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer Trial (Luveltamab tazevibulin, Pegfilgrastim)

Not yet recruiting
  • Ovarian Cancer
  • +4 more
  • (no location specified)
May 12, 2023

Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Tumor, Fallopian Tube Mucinous Tumor Trial in Rochester

Active, not recruiting
  • Fallopian Tube Clear Cell Adenocarcinoma
  • +22 more
  • Laboratory Biomarker Analysis
  • Multi-epitope Folate Receptor Alpha-loaded Dendritic Cell Vaccine
  • Rochester, Minnesota
    Mayo Clinic
Oct 7, 2022

Ovarian Cancer Trial in United States (TPIV200, Durvalumab)

Completed
Has Results
  • Ovarian Cancer
  • TPIV200
  • Durvalumab
  • Basking Ridge, New Jersey
  • +4 more
Nov 1, 2021

Advanced Solid Tumors Trial in Changchun (BAT8006 for Injection)

Recruiting
  • Advanced Solid Tumors
  • BAT8006 for Injection
  • Changchun, Jilin, China
    The First Hospital of Jilin University
Jul 26, 2022

Platinum Sensitive Ovarian Cancer, Ovarian Cancer Trial in United States (FRa peptide plus Adjuvant (GM-CSF), Adjuvant (GM-CSF)

Terminated
Has Results
  • Platinum Sensitive Ovarian Cancer
  • Ovarian Cancer
  • FRα peptide plus Adjuvant (GM-CSF)
  • Adjuvant (GM-CSF) Alone
  • Birmingham, Alabama
  • +17 more
Nov 21, 2022

Ovarian Cancer Trial in Netherlands, United States (drug, device, procedure)

Completed
Has Results
  • Ovarian Cancer
  • Phoenix, Arizona
  • +10 more
Jan 7, 2022

Lung Tumors, Lung Cancer Trial in Netherlands, United States (drug, device, procedure)

Completed
  • Lung Neoplasms
  • Lung Cancer
  • OTL38 for Injection
  • +2 more
  • Boston, Massachusetts
  • +5 more
Sep 10, 2021

Advanced Solid Tumor, Advanced Cancer, Advanced Carcinoma Trial (AMT-151)

Not yet recruiting
  • Advanced Solid Tumor
  • +18 more
  • (no location specified)
Aug 10, 2022

Ovarian Cancer, Fallopian Tube, Primary Peritoneal Cancer Trial in Birmingham (mirvetuximab soravtansine (MIRV; IMGN853))

Recruiting
  • Ovarian Cancer
  • +2 more
  • mirvetuximab soravtansine (MIRV; IMGN853)
  • Birmingham, Alabama
    University of Alabama at Birmingham Womens & Infants Center
Jun 30, 2022

Fallopian Tube Carcinosarcoma, Primary Peritoneal Carcinosarcoma, Recurrent Fallopian Tube Carcinoma Trial in Rochester (Biopsy,

Not yet recruiting
  • Fallopian Tube Carcinosarcoma
  • +14 more
  • Biopsy
  • +6 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jun 28, 2023

Human Cancers Trial in Cambridge, London (MOv18 IgE)

Completed
  • Human Cancers
  • MOv18 IgE
  • Cambridge, United Kingdom
  • +2 more
May 19, 2022

Solid Tumor Trial in United Kingdom, United States (Farletuzumab ecteribulin)

Recruiting
  • Solid Tumor
  • Farletuzumab ecteribulin
  • Tucson, Arizona
  • +26 more
Jan 30, 2023

Epithelial Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube Cancer Trial in Worldwide (Mirvetuximab soravtansine,

Completed
  • Epithelial Ovarian Cancer
  • +2 more
  • Mirvetuximab soravtansine
  • +4 more
  • Birmingham, Alabama
  • +15 more
Dec 13, 2021

Breast Cancer Trial in United States (Low dose FRa vaccine, Cyclophosphamide, High dose FRa vaccine)

Completed
  • Breast Cancer
  • Low dose FRα vaccine
  • +2 more
  • Tampa, Florida
  • +10 more
Jul 15, 2021

IBD, Rheumatoid Arthritis Trial in Groningen (OTL38, Fluorescence Imaging)

Not yet recruiting
  • IBD
  • Rheumatoid Arthritis
  • Groningen, Netherlands
    University Medical Center Groningen
May 19, 2022

BRCA1 Gene Mutation, BRCA2 Gene Mutation, Folate Receptor Alpha Positive Trial in Columbus (other, biological, drug)

Active, not recruiting
  • BRCA1 Gene Mutation
  • +9 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Sep 16, 2022

Ovarian Cancer, Ovarian Carcinoma, Ovary Cancer Trial in Spain, United States (STRO-002)

Recruiting
  • Ovarian Cancer
  • +6 more
  • Tucson, Arizona
  • +25 more
Dec 20, 2021

Non Small Cell Lung Cancer Trial (EC145, EC145 + Docetaxel, Docetaxel)

Completed
  • Non Small Cell Lung Cancer
  • (no location specified)
Mar 30, 2021